|
HHS SARS-CoV-2 Assay Development Task orders
|
Committee, Work group, Advisory group, or Task Force
|
BARDA
|
NIAID
|
Assays are being developed, qualified and validated to be shared across government studies
|
|
HHS SARS-CoV-2 Immune Assay Testing of Ph3 clinical samples- Task Order
|
Resource Development
|
ASPR
|
NIAID
|
Coordination of testing of Phase 3 clinical samples from HHS Coordination Operations and Response Element (H-CORE) peformers in H-CORE Assays (Microneutralization assay)
|
|
HHS Smoking Cessation Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIMHD, NCI
|
Discusses tobacco cessation strategies, opportunities for collaborations among HHS agencies, and the newest evidence around tobacco cessation research.
|
|
HHS Social Determinants of Health Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ACL, ACF, AHRQ, CDC, HRSA, IHS, OASH, FDA, CMS, SAMHSA
|
NIMHD, NIA, NICHD
|
The HHS SDoH Workgroup has developed a strategic vision to make health outcomes more equitable by improving the delivery of, and integration between healthcare and social services with a particular focus on individuals and populations in government health and human service programs at high risk for adverse outcomes. The SDoH workgroup identifies how HHS can address SDoH and work with other federal, state, local, tribal, and private sector partners to both ascertain and achieve shared objectives.
|
|
HHS Strategic Plan FY 2022-2026: Subcommittee for Objective 3.4
|
Committee, Work group, Advisory group, or Task Force
|
ASFR, CDC, ACF, SAMHSA, HRSA, ACL, ASPE
|
NICHD, NIMH
|
This subcommittee shares knowledge and expertise about HHS priorities and programs that will lead to the strategies at the heart of the HHS Strategic Plan Objective 3.4 to increase safeguards to empower families and communities to prevent and respond to neglect, abuse and violence, while supporting those who have experienced trauma or violence.
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NIAID
|
The Tick-Borne Disease Working Group was established by Congress in 2016 as part of the 21st Century Cures Act to provide subject matter expertise and to review federal efforts related to all tick-borne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The focus of this effort is the development of a report to the Secretary of Health and Human Services and Congress on the findings and any recommendations of the Working Group for the federal response to tick-borne disease prevention, treatment, and research, as well as how to address gaps in these areas.
|
|
HHS Tobacco Control Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, SAMHSA, OS
|
NIMHD, NCI, NIDA
|
The committee coordinates and initiates tobacco control activities across HHS agencies.The Committee meets monthly to promote information exchange and collaboration across HHS on a wide array of tobacco prevention and control issues, and to update members on the latest relevant research findings.
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA, OASH, ONC
|
NIDDK, NIDA, OD/DPCPSI/OAR, NIAID
|
The Department of Health and Human Services (HHS) Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report. (Although the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Drug Abuse, the National Institute of Allergy and Infectious Diseases, and the NIH Office of AIDS Research represent the National Institutes of Health as Working Group members, other NIH Institutes/Centers/Offices also provide input to the VHIG through their participation in the Trans-NIH Committee on Viral Hepatitis.) The working group helped develop the 2021-2025 Viral Hepatitis National Strategic Plan.
|
|
HHS Zika Vaccine Testing Task Orders Coordination
|
Resource Development
|
ASPR
|
NIAID
|
Zika vaccine testing contract efforts are being coordinated through this Department of Health and Human Services (HHS) partner meeting.
|
|
HHS-NASA Scientific Potential/Actual Collaborative Efforts (SPACE) group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, ASPR, OASH
|
NCATS, FIC, NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, OD/IMOD
|
Scientific interest group joint with the National Aeronautics and Space Administration (NASA) and other Department of Health and Human Services (HHS) OpDivs convened to explore areas of potential joint collaborative interest.
|